The present invention is concerned with a genetically modified live herpesvirus vaccine of which the live herpesviruses are not shed into the environment by a vaccinated animal. This can be achieved by deleting an essential gene of the herpesvirus and propagating this deletion mutant in a cell line expressing the gene product of the essential gene. The reduced shedding characteristic of such a vaccine is in particular advantageous in a vector vaccine.
展开▼
